Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
53.9M
-
Number of holders
-
112
-
Total 13F shares, excl. options
-
48.6M
-
Shares change
-
-4.7M
-
Total reported value, excl. options
-
$676M
-
Value change
-
-$145M
-
Put/Call ratio
-
1.58
-
Number of buys
-
60
-
Number of sells
-
-43
-
Price
-
$13.90
Significant Holders of Tyra Biosciences, Inc. - Common Stock, par value $0.0001 per share (TYRA) as of Q4 2024
135 filings reported holding TYRA - Tyra Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q4 2024.
Tyra Biosciences, Inc. - Common Stock, par value $0.0001 per share (TYRA) has 112 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.6M shares
of 53.9M outstanding shares and own 90.21% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (10.6M shares), Canaan Partners XI LLC (4.18M shares), Alta Partners Management Company, L.P. (4.08M shares), Nextech Invest Ltd. (4.06M shares), BVF INC/IL (3.94M shares), FMR LLC (3.11M shares), Boxer Capital Management, LLC (2.03M shares), TCG Crossover Management, LLC (1.99M shares), JANUS HENDERSON GROUP PLC (1.75M shares), and BlackRock, Inc. (1.72M shares).
This table shows the top 112 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.